Carandini T, Pietroboni AM, Sacchi L, De Riz MA, et al. Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression. Mult Scler 2020 May 28:1352458520926459. doi: 10.1177/1352458520926459.
PMID: 32463329